| Net Cash Provided by (Used in) Operating Activities |
$127,872,000 |
USD |
-13% |
Q2 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$65,481,000 |
USD |
25% |
Q2 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$249,175,000 |
USD |
-51% |
Q2 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
250,000,000 |
shares |
0% |
Q3 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$55,822,000 |
USD |
-261% |
Q2 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$147,343,000 |
USD |
-66% |
Q3 2025 |
Q2 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$29,342,000 |
USD |
13% |
Q2 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$45,641,000 |
USD |
-15% |
Q1 2025 |
FY 2024 |
| Deferred Tax Assets, Gross |
$260,479,000 |
USD |
23% |
Q1 2025 |
FY 2024 |
| Operating Lease, Liability |
$15,891,000 |
USD |
-13% |
Q3 2025 |
Q2 2025 |
| Depreciation |
$371,211,000 |
USD |
6% |
Q3 2025 |
Q2 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$164,393,000 |
USD |
109% |
Q3 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$27,887,000 |
USD |
0.19% |
Q3 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$3,232,000 |
USD |
18% |
Q3 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$3,201,000 |
USD |
14% |
Q3 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$2,438,000 |
USD |
-12% |
Q3 2025 |
Q2 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$282,103,000 |
USD |
18% |
Q1 2025 |
FY 2024 |
| Preferred Stock, Shares Issued |
400 |
shares |
0% |
Q3 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$1,629,000 |
USD |
-18% |
Q3 2025 |
Q2 2025 |
| Preferred Stock, Shares Outstanding |
400 |
shares |
0% |
Q3 2025 |
Q2 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$20,000 |
USD |
-57% |
Q3 2025 |
Q2 2025 |
| Interest Expense |
$272,888,000 |
USD |
6.8% |
Q3 2025 |
Q2 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q2 2025 |